Page last updated: 2024-08-25

spirobromin and cytarabine

spirobromin has been researched along with cytarabine in 1 studies

*Cytarabine: A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) [MeSH]

*Cytarabine: A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grasmane, DV; Iavorskiĭ, LI1

Other Studies

1 other study(ies) available for spirobromin and cytarabine

ArticleYear
[Acute leukemia with blasts in the shape of a hand mirror].
    Terapevticheskii arkhiv, 1987, Volume: 59, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Histocytochemistry; Humans; Leukemia, Myeloid, Acute; Lymphocytes; Male; Middle Aged; Spiro Compounds; Vincristine

1987